Receptor specificity of arrestins can be enhanced by targeted mutagenesis.
Arrestins selective for neuropeptide Y1 over Y2 receptor were developed.
Mutations differentially affect agonist-dependent and -independent recruitment.
Receptor-specific non-visual arrestins are novel tools for research and therapy.